Portable Sample-to-Answer PCR System Enables Multiplex Real-Time Detection of 27 Targets
By LabMedica International staff writers Posted on 13 Sep 2022 |
A hand-held, battery-operated mobile thermocycler that weighs just over two pounds and is designed for performing PCR, RT-PCR, qPCR, and isothermal tests on the go enables multiplex real-time detection of up to 27 targets.
Franklin is the latest field-ready mobile thermocycler from Biomeme Inc. (Philadelphia, PA, USA) that can help determine the presence or absence of the target(s) in the sample and even quantify the starting quantity in less than an hour. Compact, lightweight and battery-operated for maximum portability, Franklin is optimized to enable a full day's work out in the field on a single charge of the internal battery. The thermocycler allows users to run experiments offline using the internal battery that powers up to six runs depending on the protocol, then sync via on-board Wi-Fi/cellular. The mobile qPCR thermocycler performs to the standard used by the most advanced labs, but requires no lab equipment or special experience to use. Franklin has been designed by scientists and built for performance, but enables users without PCR-expertise to easily run PCR in the field.
Franklin comes in three different versions, giving users the freedom to start small with a one-color, 9-well mobile qPCR thermocycler and the ability to conveniently add up to two additional color channels through its free companion mobile app, Biomeme Go. The app wirelessly pairs with Franklin so that users can program custom thermocycling parameters, manage their experiments, and more. Its integrated barcode scanner helps prevent human errors by letting the team quickly scan their tests to load pre-determined protocols. Users can simultaneously test up to nine samples or 27 targets using Green (FAM/SYBR), Amber (TexasRedX), and/or Red (ATTO647N) channels. Featuring a point-of-need design, Franklin has been developed for applications that are time and location-sensitive, where results from the field need to be actionable ASAP.
Related Links:
Biomeme Inc.
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans